Immutep (IMMP) jumps 15% on positive results from a late-stage study evaluating its candidate, efti, in combination with Keytruda to treat first-line...

Cartesian (RNAC) announced that the phase IIb study in MG patients has achieved its primary endpoints. However, the stock nosedives following an...

Kazia (KZIA) surges after positive data from a phase II/III study on its lead pipeline drug in patients with glioblastoma. Based on this data, it...

Verona Pharma (VRNA) surges on the recent FDA approval for its lead drug, which is the first inhaled COPD product with a novel mechanism of action in...

By Dai WenhongOn July 1, the 2024 “Chinese Bridge” South African Primary and Secondary School Principals delegation to China, organised by South...

Fremantle have coughed up a chance to break into the top two after a late surge from Hawthorn, with James Sicily kicking two goals as the inspired...

Inovio (INO) soars 19% as its lead candidate, INO-3107, receives the innovative medicine tag under the U.K.'s Innovative Licensing and Access Pathway...

 He is a man of two notable parts. A computer engineer and an accidental actor. Ojo Emmanuel Ayodele never had the ambition to act. He has however,...

This special report was written with contributions from States Newsroom’s 39 state news outlets. WASHINGTON — The Electoral College could help...

United Therapeutics' (UTHR) late-stage study is evaluating Tyvaso inhalation solution in IPF patients living outside the United States and Canada.